Age-specific false positives and the clinical pathway for a whole-blood DNA-methylation burden screen in older adults and carriers of clonal hematopoiesis: an open-data evaluation
Abstract Background. Whole-blood DNA-methylation readouts are proposed for early detection of myeloid neoplasms, but false positives in their intended users (older adults, many with clonal hematopoiesis of indeterminate potential [CHIP]) are unstudied. Objective. To measure age-specific false positives of a fixed 48-locus methylation burden call and model what a positive result should trigger. Methods. Pre-specified, public-data analysis. A positive call was ≥ 4 of 40 evaluable loci shifted ≥ 0.20 β from a reference built on 732 adults. It was applied to 917 samples from three cohorts without known myeloid disease (one pipeline from raw arrays), 540 repeat-sampling intervals and, as a sensitivity analysis, 2,639 processed samples. CHIP effects came from a meta-analysis (N = 8,196). A decision model compared single and repeat-draw strategies in CHIP carriers and unselected adults ≥ 60. Results. Positive calls rose with age: 0.3% (< 60 y), 1.9% (60–69), 2.5% (70–79) and 7.5% (≥ 80; 95% CI 4.3–12.7). Odds ratio per 10 years 2.22 (1.21–4.07). On repeat sampling, 6 of 17 positive draws (35%; 17–59) remained positive after a median 5.6 years. Published CHIP effects do not reach the call threshold at any locus. At an assumed sensitivity of 0.50 and age 70–79, positive predictive value was 1.8% in unselected adults and 9–29% in CHIP carriers (54% with a repeat draw); net benefit was near zero in unselected adults (at most 0.3 per 1,000) and positive in CHIP carriers (up to 9.8 per 1,000). Conclusions. False positives are infrequent below 80 years and rise thereafter. The plausible use is in known CHIP carriers: a confirmatory repeat draw, then hematologic work-up. Pre-diagnostic sensitivity remains unmeasured.
Authors
- Frederic Scheer (ORCID: https://orcid.org/0009-0000-9984-6337)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-10397076/v2
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- preprint